Lifespan Research Institute

Category: News

New Drug to Slow Aging Heading to the Clinic

The biotechnology company PureTech are moving towards human clinical trials with a new therapy that may slow down the aging process and combat age-related disease. The company has licensed two

Some people think only the rich will afford life extension.

Will Increased Lifespans Be Only for the Rich?

The concern that rejuvenation biotechnologies might cause social disparity and further widen the gap between rich and poor is one of the most commonly raised ones, probably second only to

Dr. Aubrey de Grey – Reimagine Aging

For many of you reading this article, Dr. Aubrey de Grey needs little or no introduction. However, for those less well acquainted with his work, he is one of the most prominent scientists

Reprogramming Brain Cells Offers Hope for Parkinson’s

Parkinson’s disease is one of the most well known of the neurodegenerative diseases. The symptoms include tremors and loss of motor control, which are caused by the loss of dopamine producing neurons in the brain. In fact, most of us lose these neurons as we age,

New Drug to Slow Aging Heading to the Clinic

The biotechnology company PureTech are moving towards human clinical trials with a new therapy that may slow down the aging process and combat age-related disease. The company has licensed two new drug candidates, derivatives of the drug Rapamycin, from pharmaceutical giant Novartis. PureTech have recently announced

Scientists Reverse DNA Damage in Mice. Human Trials are Next.

DNA is a critical part of cells, the instruction manual for building them. While DNA is well protected within the cell nucleus, damage does occur; therefore, DNA repair is absolutely essential for cell function, cell survival, and the prevention of cancer. The good news is that

Some people think only the rich will afford life extension.

Will Increased Lifespans Be Only for the Rich?

The concern that rejuvenation biotechnologies might cause social disparity and further widen the gap between rich and poor is one of the most commonly raised ones, probably second only to concerns of overpopulation. Like many others, this concern may appear valid at first, but it does

Kelsey Moody – Developing a Therapy for Age Related Blindness

New medical technologies need bold researchers to make the leap from the laboratory table to hospitals and clinics, where they can improve or even save lives. Kelsey Moody, a 30-year-old scientist from Beekmantown, is one such researcher. Kelsey is especially interested in the treatment of age-related

The Record Lifespan of 122 Years Could Be Surpassed

Today, February 21, is the birthday of Jeanne Louise Calment – the oldest verified human being ever, who managed to live an amazing 122 years and 164 days! Jeanne was an independent and positive person, and she managed to live all alone until age 110. After a fire

Old lady looking sad

Age-Related Blindness Drug Moving to the Clinic

The development pipeline for new drugs and therapies is a long one, and, on average, it can take up to 17 years to research, test, and bring a new drug to market [1]. The reasons for this are myriad and complex, and they include the demanding

Four Main Economic Implications of an Aging Population

Most of the generation born in the 1980s enjoyed watching the science-fiction adventure comedy film “Back to the Future”. The plot is built around the idea that, by using a time machine, one can go back in time to fix things that have gone wrong in

From mechanic to medicine: How one man became a scientist

Today, we will cover a story about how a member of our community, Mike Daniels, car mechanic turned cancer researcher, was inspired by the work of the SENS Research Foundation to address age-related diseases. What follows is an emotional, gritty but honest life story of someone who took action

According to the U.S. Department of Labor, women make approximately 80% of the health care decisions for their families.

Why Women Can Benefit The Most From Rejuvenation Tech

The world is currently experiencing a period of rapid population aging, with estimates stating that by 2050, about 22% of the global  population will be aged 60 years or older;  by the end of this century, that percentage might be potentially as high as 33%. This

Intrinsic Resistance to the Idea of Life Extension or Wrong Messaging?

Most advocates of life extension report facing resistance to the idea of increased lifespans by medical means when trying to disseminate it among the general public. Resistance manifests itself in many forms, ranging from concerns such as overpopulation to concerns about unequal access to life-extending treatments.

The Fountain of Youth Could Be Closer to Hand Than We Thought

There has been a lot of hype and hope over transfusing old people with young blood in an attempt to rejuvenate the body in a similar manner to earlier heterochronic parabiosis experiments, in which the circulatory systems of an old and a young mouse were linked

Trust me, I’m a “Biologist” joins forces with LEAF

We are very pleased to announce that Trust me, I’m a “Biologist”, a popular science and biology page, has joined the Lifespan Network, a group of like-minded groups and organizations working in science.   With a community of over 739,000 readers, this is a very popular science page

Dr. Aubrey de Grey – Reimagine Aging

For many of you reading this article, Dr. Aubrey de Grey needs little or no introduction. However, for those less well acquainted with his work, he is one of the most prominent scientists in the field of rejuvenation biotechnology. More than fifteen years ago, Aubrey took up the challenge